ElectroCore is a bioelectric medicine healthcare company, which develops a non-invasive self-administered Vagus Nerve Stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, respiratory, gastroenterology, and headaches. It focuses on primary headaches, such as migraine and cluster and trials in epilepsy, gastric motility disorders, depression, and anxiety. The Company sells its products to patients through healthcare professionals in the United Kingdom, Germany, Italy, Australia, and Canada.
Gross profit (Q1, 2020)
Gross profit margin (Q1, 2020), %
Net income (Q1, 2020)
EBIT (Q1, 2020)
Market capitalization (12-Aug-2020)
Closing stock price (12-Aug-2020)
ElectroCore has 1.75k Twitter Followers. The number of followers has increased 5.3% month over month and increased 9.5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was ElectroCore founded?
ElectroCore was founded in 2005.
Who are ElectroCore key executives?
ElectroCore's key executives are Daniel S. Goldberger, JP Errico and Peter S. Staats.
How many employees does ElectroCore have?
ElectroCore has 51 employees.
What is ElectroCore revenue?
Latest ElectroCore annual revenue is $2.4 m.
What is ElectroCore revenue per employee?
Latest ElectroCore revenue per employee is $46.9 k.
Who are ElectroCore competitors?
Competitors of ElectroCore include HDL Therapeutics, Wuxi Vision Pro and Decibel Therapeutics.
Where is ElectroCore headquarters?
ElectroCore headquarters is located at 150 Allen Rd #201, Basking Ridge, Bernards.
Where are ElectroCore offices?
ElectroCore has offices in Bernards, Parksville, Geretsried, Hamburg and in 1 other location.
How many offices does ElectroCore have?
ElectroCore has 5 offices.
Receive alerts for 300+ data fields across thousands of companies